Does sleep disruption impair inflammatory resolution pathways, not just raise pro-inflammatory markers?

Inflammation has an off-switch, and sleep seems to affect it

Most of us picture inflammation as something the immune system turns on. But the body also runs an active winding-down process, using molecules called specialized pro-resolving mediators, or SPMs. These are made from omega-3 fatty acids and include the resolvins. Their job is not to block inflammation but to end it and help tissue return to normal. A review of sleep and immunity describes sleep as influencing these counter-inflammatory mechanisms, including pro-resolving pathways, alongside the more familiar rise in pro-inflammatory signaling [4].

That distinction matters for how we read the question. If poor sleep only pushed up pro-inflammatory markers, you could imagine the system still resolving inflammation on schedule once the trigger passed. If poor sleep also weakens the resolution side, inflammation could linger even when the alarm has quieted. The experimental work points to the second picture.

What a 19-day sleep-lab study actually measured

The clearest evidence comes from a controlled inpatient study of 24 healthy adults aged 20 to 42. Each participant completed two 19-day protocols, one with repeated nights of short and disrupted sleep and one with an undisturbed eight-hour sleep opportunity, with the order compared within the same person [1]. The researchers measured D-series and E-series resolvins directly in blood plasma.

During disrupted sleep, the precursor for D-series resolvins, 17-HDHA, was lower than in the control condition, and so were the resolvins RvD3, RvD4 and RvD5. The precursor for E-series resolvins, 18-HEPE, and RvE2 were also lower [1]. The pattern was not uniform: RvD1 was higher during disrupted sleep, RvD2 fell during disturbance and then rose during recovery, and RvE1 showed no clear effect [1]. In other words, this is a shift in a whole family of resolution molecules rather than a single switch being flipped.

The most striking part is timing. The drops in 17-HDHA, 18-HEPE and several resolvins were still present after three nights of recovery sleep at the end of the protocol [1]. That suggests the resolution side does not simply reset as soon as sleep opportunity is restored, at least over the short recovery window studied.

Does recovery sleep repair the damage?

A companion analysis of the same kind of 19-day protocol looked at sleep stages rather than just total sleep. Slow-wave sleep dropped during experimental disturbance and rebounded on the first recovery night, and the resolvins RvD2 and RvD3 followed a similar down-then-up pattern [2]. But the slow-wave sleep change itself did not correlate with the resolvin change, so the authors did not treat slow-wave sleep as the direct driver.

What did track with resolution was the broader non-REM sleep response: a larger non-REM rebound during the third recovery night went with a larger rise in RvD2 and RvD3, while a larger REM sleep response went with a lower resolvin response [2]. The authors suggest that non-REM sleep during recovery may support inflammatory resolution, but this is a correlation in a small sample, not proof of cause. It does, however, fit the idea that recovery is not instant and may depend on the kind of sleep you get back.

The same pattern appears in Long COVID

Laboratory experiments are tightly controlled but brief. A separate study asked whether the pattern shows up in people with persistent symptoms. It compared 31 people with Long COVID and 8 people who had been infected but did not develop Long COVID, using a standard questionnaire score for sleep disturbance and a morning blood sample for lipid mediators [3].

Participants with Long COVID reported more sleep disturbance and had higher levels of the pro-inflammatory mediator PGE2 than controls. Within the Long COVID group, those with high sleep disturbance had lower levels of several resolution-related molecules, including 17-HDHA, 17R/S-RvD1, 15R-LXB4 and PD1n-3 DPA, than those with lower sleep disturbance scores [3]. This is a cross-sectional association, so it cannot show that poor sleep caused the lower resolution mediators. Still, it is consistent with the experimental finding and extends it to a clinical population where unresolved inflammation is a central concern.

Taken together, the evidence supports a two-sided answer: sleep disruption is associated with both more inflammatory signaling and weaker resolution signaling. The resolution side has been shown most directly in a small controlled study of healthy adults, with the Long COVID data adding a real-world parallel rather than a causal test [1][3].

Sources used in this answer

Related research questions